HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rioko Migita Selected Research

Cerebral Infarction

5/2023A case in which baricitinib was effective for both rheumatoid arthritis and essential thrombocythemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rioko Migita Research Topics

Disease

2Rheumatoid Arthritis
05/2023 - 01/2022
1Pancytopenia
05/2023
1Arthritis (Polyarthritis)
05/2023
1Cerebral Infarction
05/2023
1Essential Thrombocythemia
05/2023
1Pulmonary Arterial Hypertension
10/2022
1Pericardial Effusion
10/2022
1Pericarditis
10/2022
1Systemic Scleroderma (Systemic Sclerosis)
10/2022
1Neoplasms (Cancer)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022

Drug/Important Bio-Agent (IBA)

1baricitinibIBA
05/2023
1C-Reactive ProteinIBA
05/2023
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2023
1Folic Acid (Vitamin M)FDA LinkGeneric
05/2023
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
10/2022
1Prednisolone (Predate)FDA LinkGeneric
10/2022
1Janus KinasesIBA
01/2022
1Janus Kinase InhibitorsIBA
01/2022
1EnzymesIBA
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022

Therapy/Procedure

1Cardiac Catheters
10/2022